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Ten years after Benedict Massell entered
medicine in 1931, rheumatic fever was the
leading cause of death for policyholders, from
the ages offive to thirteen, at the Metropolitan
Life Insurance Company. He recalls that Arnold
Bennett, in The old wives' tale, describes it as
"this dread disease". This isjust one ofthe notes
and references which occupy one quarter ofthe
text ofthis remarkable review ofthe literature
on rheumatic fever and its responsible
streptococcus. The classic descriptions ofthe
nineteenth century led up to the Harveian
lectures given by Walter Cheadle in 1888, which
Massell believes to be as complete and accurate
a clinical description as anything published
since then. He traces the history of
investigations into the disease and its
mechanisms, its streptococcus and its
prevention, and brings a mastery ofthe literature
and a love of his subject to this important book.
He reminds us that new ideas about old diseases
may be difficult for the profession to take on
board. It may be no surprise that the American
Rheumatism Association, in its rheumatism
reviews, did not accept the role ofthe
streptococcus until 1962, despite the clear
evidence presented independently by Coburn
and Collis in 1931-32.
Chapters are devoted to cause, pathogenesis,
treatment and prevention, and reflect the march
of medical science from disciplined
observation at the bedside, through to the
molecular understanding of the mechanisms
responsible for damage to the heart. As a
master of his subject, whose mind is inquisitive
and alert, Massell challenges the reader to
think about the unknown problems of the
disease, just as lucidly as he presents the
evidence which has led to the solving of some
of the former problems.
Massell was in charge of the House of the
Good Samaritan in Boston and that is where
his work was based, but it was closed in the
1970s because the disease had ceased to be a
problem: tragically, a very large collection of
sera was destroyed. The decline of the disease,
which began before penicillin was available,
depended on the poor being better housed and
less crowded at home, so that easy
transmission of the responsible types of
streptococcus became rare. But the decline in
the richer countries has not been matched in
the poorest. The book would convince the most
dismissive sceptic about inequalities in health
that rheumatic heart disease is socially
determined: it accurately reflects poverty and
poor housing. It is a pity, therefore, that, while
the author mentions the burden of rheumatic
heart disease and of streptococcal infection in
developing countries, he nowhere addresses
this appalling burden. It is bewildering for the
thoughtful physician to consider only one of its
demands-how can secondary prophylaxis,
which is very well discussed in the text, be
made available where health care is
rudimentary? This contemporary challenge is
just as daunting as the problems which
confronted the Armed Forces medical services
when there were epidemics of the responsible
streptococci among vast camps of recruits
during the Second World War.
Massell has not written this absorbingly
clear review as a spectator or as a mere
retriever from Medline, but from his own daily
contact with the disease and its perplexities
since he set out in 1931. It is to be hoped that
the decline and fall of such a dread disease in
the rich world will, before long, be matched by
a similar decline in the poorest countries of the
world. That is an even bigger task which offers
even greater rewards than the challenges,
already met and overcome, by the many
investigators to whom the author has so
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generously paid tribute in this splendid book.
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Since 1950 or so, placebos and their effect
have generated a considerable interest in certain
medical communities, in particular among
psychiatrists and the designers ofclinical trials,
yet the only significant external study ofthis
phenomenon to appear has been Howard
Brody's doctoral investigation, Placebos and the
philosophy ofmedicine, published in 1980. In
1997, however, three book-length studies were
produced: a collection ofessays edited by Anne
Harrington (Theplacebo effect: an
interdisciplinary exploration, Harvard
University Press); Arthur and Elaine Shapiro's
The powerfulplacebo (Johns Hopkins
University Press), and this multi-authored
Danish contribution; testimony, perhaps, to the
recent revival of interest in mind-body
relationships, in the power ofthe mind to
influence healing. The Harrington volume is
philosophical in its approach, being intended "to
push the envelope ofthinking on placebo in
ways that might help reshape how the problem
is conceived and studied ... to ponder how to
do betterjustice to the integrated ways in which
sociocultural meanings and physiological
mechanisms function fluidly within a single
human being" (p. 9). It relates largely to current
concerns over placebos, whereas the Shapiros
elegantly and accessibly take a long-term
historical perspective, from Cro-Magnon times
(c. 20,000 BC) forward to the end ofthe
twentieth century. The Shapiro emphasis is,
essentially, on the centrality of the placebo
effect in the success of medical intervention
across the centuries; in the relations ofthe
placebo to psychiatry and to clinical trials; in the
laws which govern the nonspecific but very
powerful therapeutic potential of the placebo
effect. Arthur Shapiro himself, who died in
1995, may be considered the doyen of placebo
studies: his contributions far outnumber other
entries in his own bibliography, and provide
crucial core literature for the independent
Danish investigations.
Three publications on this subject in one
year might be considered at least one too many,
but the Danes' study is by no means
superfluous. It at once complements and
extends the perspective offered by the other
two books. Like the Shapiro volume, it is
lucidly and accessibly written for a non-
specialist readership; unlike the Shapiro
volume, it consciously takes three different
approaches to its subject. In the first section,
Asbj0rn Hr6bjartsson explores current issues
surrounding the placebo effect. The placebo, he
argues, provides a unique focus for examining
the relationship between medical science, body,
mind, and clinical treatment. In the first place
he examines the diverse and often paradoxical
uses of the placebo concept in medical
literature (for example, that it is at once
accepted as scientific good in clinical
experiment yet utilized as an expression of
doubt, or as an implication of pseudo-science,
when used of complementary therapies), then
he discusses selected definitions of the terms
"placebo" and "placebo effect". The third
section deals with the transformation of the
placebo effect, from a part ofeveryday
medicine before World War II, to a new central
role in the randomized clinical trial after that
War. It is an area dealt with more fully and
reliably by the Shapiros, but it is good to be
reminded, by the account of Johannes Fibiger's
pioneering application of Louis' numerical
method in his 1898 investigations in
Copenhagen into the effectiveness of
diphtheria anti-toxin (p. 33), that serious
medical research is undertaken in countries
other than the big four (Britain, America,
France and Germany). Hr6bjartsson concludes
by discussing how to measure the placebo
effect, and its significance in clinical medicine.
The central section of the book, by Lars Ole
Andersen, deals with the placebo's historical
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